TABLE 1.
Patient data
| Patient ID | Diagnosis | Age (y) | Sex | PRETEXT stage | COG stage | Risk | Multifocal | VI | Metastasis | ICG+ |
|---|---|---|---|---|---|---|---|---|---|---|
| HB70/110 | HB | 2 | F | 1 | 1 | VLR | N | N | N | Y |
| HB73 | HB | 3 | M | 4 | 4 | HR | Y | Y | Y | NA |
| HB77 | HB | 1 | M | 2 | 1 | LR | N | Y | N | Y |
| HB78 | HB | 1 | M | 3 | 1 | IR | Y | N | N | NA |
| HB80 | HB | 1 | F | 4 | 1 | HR | N | N | Y | Y |
| HB99 | HB | 5 | M | 3 | 4 | HR | N | Y | Y | Y |
| HB102/106 | HB | 8 | M | 3 | 2 | IR | Y | Y | N | Y |
| HB103/113 | HB | 5 | F | 4 | 4 | HR | Y | Y | Y | Y |
| HB108 | HB | 1 | M | 4 | 3 | IR | Y | Y | N | NA |
| HB109 | HB | 0.42 | F | 2 | 1 | VLR | N | Y | N | NA |
| HB112 | HB | 1 | F | 3 | 2 | HR | N | Y | Y | Y |
| HB134 | HB | 1 | M | 3 | 1 | IR | N | Y | N | Y |
| HB83/114/116 | HCC | 7 | F | 4 | 4 | HR | Y | Y | Y | Y |
| HB105 | FLC | 21 | M | 3 | 2 | HR | Y | Y | Y | Y |
| HB119 | FLC | 8 | M | 4 | NA | HR | Y | Y | N | NA |
| HB71 | MH | 2 | F | 2 | NA | NA | N | N | N | NA |
Note: Patient age shown at the time of the first sample. NA for ICG+ indicates that ICG was not used during surgery so information about ICG accumulation is not available.
Abbreviations: COG, Children’s Oncology Group; FLC, fibrolamellar carcinoma; HB, hepatoblastoma; HR, high-risk; ICG, indocyanine green; LR, low risk; MH, mesenchymal hamartoma; NA, not available; PRETEXT, pretreatment extent of disease; VI, vascular invasion; VLR, very low risk.